These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 2287082)

  • 21. Cytopathology--a multiparameter approach.
    Astarita RW
    West J Med; 1991 Jan; 154(1):96-7. PubMed ID: 2024523
    [No Abstract]   [Full Text] [Related]  

  • 22. [The role of cellular kinetics as a predictive index of response to radiotherapy: state of the art and future perspectives].
    Sannazzari GL
    Radiol Med; 1993 Sep; 86(3):322-6. PubMed ID: 8210542
    [No Abstract]   [Full Text] [Related]  

  • 23. [Flow cytometry in the detection of residual disease].
    Lamy B; Hervé P; Tissot C; Peters A
    Pathol Biol (Paris); 1988 Jan; 36(1):29-36. PubMed ID: 2966335
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Quantitative DNA analysis of fresh solid tumors by flow and image cytometric methods: a comparison using the Roche Pathology Workstation Image Analyzer.
    Ellison DA; Maygarden SJ; Novotny DB
    Mod Pathol; 1995 Apr; 8(3):275-81. PubMed ID: 7617654
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Detection of genetic changes in Barrett's adenocarcinoma and Barrett's esophagus by DNA in situ hybridization and immunohistochemistry.
    Krishnadath KK; Tilanus HW; Alers JC; Mulder AH; van Dekken H
    Cytometry; 1994 Feb; 15(2):176-84. PubMed ID: 8168405
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Cytokinetic effects of anticancer drugs on a human lung cancer cell line using monoclonal antibody against bromodeoxyuridine].
    Miyamoto H; Isobe H; Ito M; Mizuno S; Kawakami Y
    Gan To Kagaku Ryoho; 1986 Dec; 13(12):3541-5. PubMed ID: 3789763
    [No Abstract]   [Full Text] [Related]  

  • 27. [In vitro studies of the cell cycle of mouse myelomonocytic leukemia using a fluorescence activated cell sorter and autoradiography].
    Gao FM; Li XL; Huang H; Wang WH
    Zhonghua Zhong Liu Za Zhi; 1987 Jan; 9(1):10-3. PubMed ID: 3474131
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of denaturation with HCl on the immunological staining of bromodeoxyuridine incorporated into DNA.
    Sasaki K; Adachi S; Yamamoto T; Murakami T; Tanaka K; Takahashi M
    Cytometry; 1988 Jan; 9(1):93-6. PubMed ID: 2457476
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Topoisomerase II-alpha expression in different cell cycle phases in fresh human breast carcinomas.
    Villman K; Ståhl E; Liljegren G; Tidefelt U; Karlsson MG
    Mod Pathol; 2002 May; 15(5):486-91. PubMed ID: 12011253
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Flow cytometric DNA ploidy and cells phase fractions in recurrent human pituitary adenomas. A correlative study of flow cytometric analysis and the expression of proliferating cell nuclear antigen.
    Chae YS; Flotte T; Hsu DW; Preffer F; Hedley-Whyte ET
    Gen Diagn Pathol; 1996 Oct; 142(2):89-95. PubMed ID: 8950573
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tumor cell heterogeneity: its determination by flow cytometric analysis of intracellular pH.
    Alabaster O; Carr KC; Leondaridis L
    Methods Achiev Exp Pathol; 1984; 11():96-110. PubMed ID: 6700438
    [No Abstract]   [Full Text] [Related]  

  • 32. Discrimination of G2 and mitotic cells by flow cytometry based on different expression of cyclins A and B1.
    Gong J; Traganos F; Darzynkiewicz Z
    Exp Cell Res; 1995 Sep; 220(1):226-31. PubMed ID: 7664839
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Multiparameter analysis using flow cytometry as additional tool for bladder cancer diagnosis].
    Knuechel R; Wieland W; Nicolai H; Hofstaedter F
    Verh Dtsch Ges Pathol; 1993; 77():204-8. PubMed ID: 7511281
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Flow cytometry in clinical cancer research.
    Barlogie B; Raber MN; Schumann J; Johnson TS; Drewinko B; Swartzendruber DE; Göhde W; Andreeff M; Freireich EJ
    Cancer Res; 1983 Sep; 43(9):3982-97. PubMed ID: 6347364
    [No Abstract]   [Full Text] [Related]  

  • 35. Multiple cell markers and flow cytometry in invasive bladder cancer.
    Javadpour N
    Prog Clin Biol Res; 1988; 260():189-201. PubMed ID: 3283759
    [No Abstract]   [Full Text] [Related]  

  • 36. Emerging impact of flow cytometry in predicting recurrence and survival in breast cancer patients.
    McGuire WL; Dressler LG
    J Natl Cancer Inst; 1985 Sep; 75(3):405-10. PubMed ID: 3861896
    [No Abstract]   [Full Text] [Related]  

  • 37. [Measurement of DNA content and analysis of chromosome using flow cytometry].
    Akagi K; Uda M; Itagaki Y; Tanaka Y
    Gan No Rinsho; 1989 Oct; 35(13):1559-65. PubMed ID: 2531240
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cell proliferation in colorectal adenomas containing invasive carcinoma.
    Risio M; Rossini FP
    Anticancer Res; 1993; 13(1):43-7. PubMed ID: 8097391
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Simultaneous triple staining for hypoxia, proliferation, and DNA content in murine tumours.
    Webster L; Hodgkiss RJ; Wilson GD
    Cytometry; 1995 Dec; 21(4):344-51. PubMed ID: 8608732
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Rapid in vitro bromodeoxyuridine labeling method for monitoring of therapy response in solid human tumors.
    Hemmer J
    Cytometry; 1990; 11(5):603-9. PubMed ID: 2379451
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.